Susan Whoriskey

This inventor holds 15 USPTO granted patents and 28 published patent applications and 1 EPO patent, primarily in Biologics Production. Top assignees: Modernatx, Inc., Moderna Therapeutics, Inc.. Active years: 2015-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Susan Whoriskey. Retrieved from https://idiyas.com/inventor/susan-whoriskey

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 28)

% Patents Active = 93.3

EPO Patents = 1 (Patent Applications = 17)

Average Co-Inventor Count = 9.3

ph-index = 12

Forward Citations = 940(Granted Patents)

Company Filing History:

Moderna Therapeutics, Inc.

patents

Years Active: 2015-2020

Loading Chart...

Areas of Expertise:

Biologics

Modified Polynucleotides

RNA Synthesis

Proteins

Oncology-related Proteins

Enzymes

Polymerases

Human Disease

Secreted Proteins

Cytoplasmic Proteins

Nuclear Proteins

Peptides

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10772975 - Modified Polynucleotides for the production of biologics and proteins associated with human disease (2020-09-15),

2. 9828416 - Modified polynucleotides for the production of secreted proteins (2017-11-28),

3. 9827332 - Modified polynucleotides for the production of proteins (2017-11-28),

4. 9814760 - Modified polynucleotides for the production of biologics and proteins associated with human disease (2017-11-14),

5. 9790531 - Enzymes and polymerases for the synthesis of RNA (2017-10-17),

6. 9782462 - Modified polynucleotides for the production of proteins associated with human disease (2017-10-10),

7. 9675668 - Modified polynucleotides encoding hepatitis A virus cellular receptor 2 (2017-06-13),

8. 9587003 - Modified polynucleotides for the production of oncology-related proteins and peptides (2017-03-07),

9. 9572897 - Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins (2017-02-21),

10. 9572896 - In vivo production of proteins (2017-02-21),

11. 9512456 - Enzymes and polymerases for the synthesis of RNA (2016-12-06),

12. 9504734 - Modified polynucleotides for the production of nuclear proteins (2016-11-29),

13. 9254311 - Modified polynucleotides for the production of proteins (2016-02-09),

14. 9221891 - In vivo production of proteins (2015-12-29),

15. 8999380 - Modified polynucleotides for the production of biologics and proteins associated with human disease (2015-04-07),

Certainly! Here is an article about inventor Susan Whoriskey's dedication to innovation:

Title: Susan Whoriskey: Pioneering Inventor Shaping the Future

Introduction:

Susan Whoriskey, a visionary inventor based in Belmont, MA (US), has left an indelible mark on various industries with her relentless pursuit of excellence and passion for innovation. With 15 patents under her belt, Susan is recognized as a trailblazer in the field of biologics and proteins associated with human disease.

Latest Patents:

Her latest patents include groundbreaking inventions such as "Modified Polynucleotides for the Production of Biologics and Proteins Associated with Human Disease" and "Modified Polynucleotides for the Production of Proteins." These patents revolutionize the pharmaceutical industry by introducing compositions and methods for the preparation, manufacture, and therapeutic use of polynucleotides and mRNA molecules.

Career Highlights:

Susan's exceptional career includes collaborations with leading companies such as Moderna Therapeutics, Inc., where she played a pivotal role in driving innovation and pushing the boundaries of biotechnology. Her expertise in lipid nanoparticles and mRNA technologies has paved the way for novel approaches in drug delivery and therapeutics.

Collaborations:

Throughout her career, Susan has worked closely with esteemed colleagues such as Stephane Bancel and Tirtha Chakraborty, who share her passion for innovation and dedication to advancing scientific research. These collaborations have resulted in groundbreaking discoveries and pushed the boundaries of what is possible in the biotech industry.

Conclusion:

In conclusion, Susan Whoriskey's contributions to the field of biotechnology are nothing short of extraordinary. Her innovative spirit, coupled with her dedication to excellence, continues to inspire future generations of inventors and researchers. Susan's legacy serves as a testament to the power of innovation and the transformative impact it can have on society as a whole.

Profile summary based on public USPTO records.